SIMCERE PHARMACEUTICAL GROUP Deferred Tax Assets, Operating Loss Carryforwards
SIMCERE PHARMACEUTICAL GROUP had Deferred Tax Assets, Operating Loss Carryforwards of CNY 76.06 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2013-04-26
- 2012-12-31: Deferred Tax Assets, Operating Loss Carryforwards 76.06M CNY.
- 2011-12-31: Deferred Tax Assets, Operating Loss Carryforwards 48.57M CNY.
CNY
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2012-12-31 | 76.06M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 48.57M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2012-12-31 | $12.21M 20-F · filed 2013-04-26 |